ISRCTN49711898已完成未知
Termination Of Pregnancy at 64-140 days
Concept Foundation (Switzerland)0 个研究点目标入组 670 人开始时间: 2013年10月2日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 670
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- Female
入选标准
- •1. Good general health
- •2. Older than the age for legal consent
- •3. Requesting and eligible for legal termination of pregnancy
- •4. Duration of pregnancy 64-140 days on Day 1 (mifepristone administration), verified by ultrasound
排除标准
- •1. No contra-indications towards mifepristone and misoprostol
- •2. No serious present or past ill health
- •3. Molar or extrauterine pregnancy or threathend abortion, >1 low segment C-section
研究者
相似试验
尚未招募
不适用
Second- and third-trimester termination of pregnancy: physiological, neurobiological and psychological adaptation and long-term consequencesP96.4O04Termination of pregnancy, affecting fetus and newbornMedical abortionDRKS00033060niklinik RWTH Aachen102
进行中（未招募）
1 期
Study to assess the effect of bimagrumab withdrawal in older adults with sarcopenia (low muscle mass and mobility).SarcopeniaMedDRA version: 19.0 Level: PT Classification code 10063024 Term: Sarcopenia System Organ Class: 10028395 - Musculoskeletal and connective tissue disordersEUCTR2015-000471-27-BEovartis Pharma Services AG240
进行中（未招募）
1 期
Study to assess the effect of bimagrumab withdrawal in older adults with sarcopenia (low muscle mass and mobility).EUCTR2015-000471-27-ESovartis Farmacéutica, S.A.240
进行中（未招募）
1 期
Ensayo clínico de retirada de 24 semanas de duración, doble ciego, randomizado y controlado frente a placebo, con una fase abierta de introducción de 16 semanas y 64 semanas de seguimiento abierto, para evaluar la eficacia y seguridad de Tocilizumab en pacientes con Artritis Idiopática Juvenil activa de curso poliarticular.A 24 week randomized double-blind, placebo controlled withdrawal trial with a 16 week open label lead-in phase, and 64 week open label follow-up, to evaluate the efficacy and safety of tocilizumab in patients with active polyarticular-course juvenile idiopathic arthritisEUCTR2009-011593-15-ESF. Hoffmann-La Roche Ltd188
进行中（未招募）
不适用
A clinical study in patients with Growth Hormone Deficiency to assess safety , tolerability and efficacy of TV-1106 (experimental drug).EUCTR2012-004975-37-HUTeva Pharmaceutical Industries Ltd.50